Akebia Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
AKBA on Nasdaq
Industry
Pharmaceutical Preparations
Location
245 First Street, Cambridge, MA

Insiders trading volume in the past year

Akebia Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John P. Butler CEO and President, Director $5.27M -$388K -6.86% Mar 3, 2025
Erik Ostrowski SVP, CFO, CBO & Treasurer $1.85M -$152K -7.58% Jun 30, 2025
Steven K. Burke SVP, Chief Medical Officer $1.48M -$119K -7.45% Mar 3, 2025
Richard C. Malabre SVP, Chief Accounting Officer $1.07M -$171K -13.8% Jun 9, 2025
Nicholas Grund Chief Commercial Officer $929K -$117K -11.2% Jan 31, 2025
Ellen Snow SVP, CFO and Treasurer $872K Jan 31, 2024
Michel Dahan SVP, Chief Operating Officer $847K May 13, 2024
Nicole R. Hadas SVP, Chief Legal Officer $821K May 13, 2024
David A. Spellman SVP, CFO and Treasurer $546K May 16, 2023
Adrian Adams Director $525K Jun 10, 2025
Michael W. Rogers Director $424K Jun 10, 2025
Cynthia Smith Director $422K Jun 10, 2025
Steven C. Gilman Director $400K Jun 10, 2025
Myles Wolf Director $349K Jun 10, 2025
Ron Frieson Director $339K Jun 10, 2025
Leanne M. Zumwalt Director $287K Jun 10, 2025
Violetta Cotreau SVP, Chief Accounting Officer $269K May 12, 2022
Dell Faulkingham Svp, Cco $213K Feb 28, 2022
Michael Thomas Heffernan Director $59.4K Jun 2, 2021

Recent Insider Transactions by Companies or Individuals for Akebia Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.